Medtronic To Appeal Stent Patent Ruling Backing Guidant, Pursue New Claim
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is continuing to pursue pending litigation against Guidant subsidiary Advanced Cardiovascular Systems, alleging the Multilink Duet and Solo coronary stents and Megalink peripheral stent infringe patents held by Medtronic, the company says.